Parkside Financial Bank & Trust’s Adaptive Biotechnologies ADPT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.22K	Hold	430	–	–	﹤0.01%	1684
2026 Q1	$5.97K	Buy	430 +345	+406%	+$5.5K	﹤0.01%	1768
2025 Q4	$1.38K	Hold	85	–	–	﹤0.01%	2230
2025 Q3	$1.27K	Hold	85	–	–	﹤0.01%	2188
2025 Q2	$991	Hold	85	–	–	﹤0.01%	2274
2025 Q1	$631	Buy	+85	New	+$653	﹤0.01%	2252
2022 Q3	–	Sell	-102	Closed	-$1K	–	1783
2022 Q2	$1K	Sell	102 -61	-37%	-$536	﹤0.01%	1661
2022 Q1	$2K	Buy	163 +144	+758%	+$2.26K	﹤0.01%	1552
2021 Q4	$1K	Buy	+19	New	+$582	﹤0.01%	1694

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Parkside Financial Bank & Trust's ADPT Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 430 shares worth $9.22K. The position accounts for ﹤0.01% of the portfolio, ranked #1684.

Parkside Financial Bank & Trust first reported a position in ADPT in Q4 2021 and has held it in 9 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Parkside Financial Bank & Trust held 430 shares of Adaptive Biotechnologies worth $9.22K as of Q2 2026.
Parkside Financial Bank & Trust left its Adaptive Biotechnologies share count unchanged in Q2 2026.
Adaptive Biotechnologies made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1684 holding.
Parkside Financial Bank & Trust first reported a position in Adaptive Biotechnologies in Q4 2021 and has held it in 9 quarters since.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.